Ocular Therapeutix (OCUL) is up 11.7%, or $1.30 to $12.37.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCUL:
- Ocular Therapeutix Enters Quiet Period Ahead of SOL-1 Milestone
- Strong Buy Rating for Ocular Therapeutix Backed by Enhanced Regulatory Pathway and Promising Axpaxli Trial Data
- Ocular Therapeutix price target raised to $21 from $18 at BofA
- Mizuho remains bullish on EyePoint as competitor makes move for ‘Pole Position’
- Buy Rating for Ocular Therapeutix: Accelerated Axpaxli Launch and FDA Engagement Drive Positive Outlook